Department of Neurosurgery, Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology and Genetics, Sloan Kettering Institute, New York, NY 10065, USA.
Department of Neurosurgery, Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Louis V. Gerstner, Jr., Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cell Stem Cell. 2021 May 6;28(5):894-905.e7. doi: 10.1016/j.stem.2021.02.003. Epub 2021 Feb 24.
H3.3G34R-mutant gliomas are lethal tumors of the cerebral hemispheres with unknown mechanisms of regional specificity and tumorigenicity. We developed a human embryonic stem cell (hESC)-based model of H3.3G34R-mutant glioma that recapitulates the key features of the tumors with cell-type specificity to forebrain interneuronal progenitors but not hindbrain precursors. We show that H3.3G34R, ATRX, and TP53 mutations cooperatively impact alternative RNA splicing events, particularly suppression of intron retention. This leads to increased expression of components of the Notch pathway, notably NOTCH2NL, a human-specific gene family. We also uncover a parallel mechanism of enhanced NOTCH2NL expression via genomic amplification of its locus in some H3.3G34R-mutant tumors. These findings demonstrate a novel mechanism whereby evolutionary pathways that lead to larger brain size in humans are co-opted to drive tumor growth.
H3.3G34R 突变型神经胶质瘤是大脑半球的致命肿瘤,其区域特异性和致瘤性的机制尚不清楚。我们开发了一种基于人胚胎干细胞(hESC)的 H3.3G34R 突变型神经胶质瘤模型,该模型重现了肿瘤的关键特征,具有前脑神经内胚层祖细胞的细胞类型特异性,但没有后脑前体特异性。我们表明,H3.3G34R、ATR 和 TP53 突变协同影响选择性 RNA 剪接事件,特别是抑制内含子保留。这导致 Notch 通路的组成部分,特别是 Notch2NL 的表达增加,Notch2NL 是人类特异性基因家族。我们还发现了一种通过其基因座在一些 H3.3G34R 突变型肿瘤中基因组扩增来增强 NOTCH2NL 表达的平行机制。这些发现表明了一种新的机制,即导致人类大脑更大的进化途径被篡夺来驱动肿瘤生长。